GOCM
NVS icon

Grey Owl Capital Management’s Novartis NVS Stock Holding History

Grey Owl Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,360
Closed -$865K – 51
2014
Q1 		$865K Buy
11,360
+192
+2% +$14K 1% 27
2013
Q4 		$804K Buy
+11,168
New +$776K 1.06% 28

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Grey Owl Capital Management's NVS Position: Q2 2014 in Review

Grey Owl Capital Management sold out of Novartis (NVS) in Q2 2014, closing a stake of 11,360 shares — an estimated $865K sold.

Grey Owl Capital Management first reported a position in NVS in Q4 2013 and held it in 2 quarters. The position peaked at $865K in Q1 2014. 847 funds tracked by Wall St. Rank hold NVS as of Q2 2014.

  • Grey Owl Capital Management reported no remaining Novartis position as of Q2 2014 after selling out during the quarter.
  • Grey Owl Capital Management sold 11,360 Novartis shares in Q2 2014, an estimated $865K.
  • Grey Owl Capital Management first reported a position in Novartis in Q4 2013 and held it in 2 quarters.
  • Grey Owl Capital Management's Novartis position peaked at $865K in Q1 2014.
  • 847 funds tracked by Wall St. Rank held Novartis as of Q2 2014.

Based on Grey Owl Capital Management's 13F filing for Q2 2014, filed 8 Aug 2014.